V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20161209 | 20062279 | 1.85 | 76.8 | Neo-adjuvant (N) | 2017-10-05 | 2017-10-07 | ECX | 02 | N | ECX | 100328584 |
| 20161213 | 20062280 | 1.79 | 52 | Curative (C) | 2017-07-18 | 2017-07-23 | ECX | 02 | N | ECX | 101602055 |
| 20161214 | 20062281 | null | 82 | null | 2018-08-06 | 2018-09-01 | Gemcitabine + Capecitabine | N | N | ECX | 100016926 |
| 20161216 | 20062282 | 1.75 | 88.4 | Palliative (P) | 2018-06-02 | 2018-06-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100660939 |
| 20161217 | 20062283 | 1.75 | 81 | Neo-adjuvant (N) | 2016-04-17 | 2016-04-18 | ECX | 02 | N | ECX | 100073436 |
| 20161219 | 20062284 | 1.7 | 87.8 | Palliative (P) | 2016-09-03 | 2016-09-09 | ECX | 02 | N | ECX | 100188377 |
| 20161225 | 20062285 | 1.74 | 74.6 | Palliative (P) | 2018-10-20 | 2018-11-07 | ECX | N | N | ECX | 101209655 |
| 20161226 | 20062286 | 1.6 | 74 | null | 2018-08-07 | 2018-08-24 | ECX | N | N | ECX | 101268291 |
| 20161227 | 20062287 | 1.69 | 58.2 | Palliative (P) | 2016-12-14 | 2016-12-21 | ECX | 02 | N | ECX | 100347813 |
| 20161228 | 20062288 | 1.57 | 74.05 | Palliative (P) | 2017-10-02 | 2017-10-16 | ECX | 02 | N | ECX | 100073199 |
| 20161229 | 20062289 | 1.57 | 55 | Neo-adjuvant (N) | 2018-04-15 | 2018-04-15 | ECX | 02 | N | ECX | 100990482 |
| 20161230 | 20062290 | 1.56 | 91.3 | Adjuvant (A) | 2020-10-03 | 2020-10-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100101834 |
| 20161232 | 20062291 | 1.6 | 77.6 | Neo-adjuvant (N) | 2017-04-18 | 2017-04-25 | ECX | N | Y | ECX | 101518072 |
| 20161233 | 20062292 | 1.72 | 85 | Curative (C) | 2016-03-14 | 2016-03-25 | ECX | 02 | N | ECX | 101143747 |
| 20161236 | 20062293 | 1.82 | 52.4 | Adjuvant (A) | 2018-03-10 | 2018-03-17 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100920020 |
| 20161239 | 20062294 | 1.72 | 61.2 | null | 2016-09-27 | 2016-10-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101858489 |
| 20161240 | 20062295 | 1.77 | 72.6 | Palliative (P) | 2017-11-30 | 2017-12-14 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101368580 |
| 20161244 | 20062296 | 1.76 | 49.5 | Neo-adjuvant (N) | 2019-01-19 | 2019-02-02 | ECX | N | N | ECX | 101862939 |
| 20161245 | 20062297 | 1.77 | 69 | Neo-adjuvant (N) | 2018-10-22 | 2018-11-04 | ECX | 02 | N | ECX | 101830643 |
| 20161246 | 20062298 | 1.8 | 73.9 | Curative (C) | null | 2019-02-14 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101230739 |
| 20161249 | 20062299 | 1.8 | 56.8 | Neo-adjuvant (N) | 2016-10-24 | 2016-11-15 | ECX | 2 | N | ECX | 100536899 |
| 20161250 | 20062300 | null | 63.3 | Palliative (P) | 2017-04-05 | 2017-04-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101011638 |
| 20161251 | 20062301 | 1.59 | 93.9 | Adjuvant (A) | 2019-05-28 | 2019-06-08 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100682064 |
| 20161252 | 20062302 | 1.65 | 49 | Palliative (P) | 2019-07-24 | 2019-08-11 | ECX | N | null | ECX | 101312167 |
| 20161255 | 20062303 | 1.68 | 63.2 | Palliative (P) | 2016-09-19 | 2016-09-19 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101786452 |
| 20161257 | 20062304 | 1.58 | 74.2 | Curative (C) | 2016-03-13 | 2016-03-20 | ECX | N | N | ECX | 100051994 |
| 20161258 | 20062305 | 1.64 | 63.6 | Neo-adjuvant (N) | 2018-11-11 | 2018-11-26 | ECX | N | N | ECX | 101101023 |
| 20161260 | 20062306 | 1.6 | 74.3 | Palliative (P) | 2018-08-03 | 2018-08-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100344136 |
| 20161261 | 20062307 | 1.51 | 83.2 | Neo-adjuvant (N) | 2019-12-18 | 2019-12-31 | ECX | 02 | N | ECX | 100953399 |
| 20161263 | 20062308 | 1.63 | 60.6 | Palliative (P) | 2017-05-01 | 2017-05-12 | ECX | N | N | ECX | 101559687 |
| 20161264 | 20062309 | 1.52 | 81.8 | null | 2018-07-12 | 2018-07-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101640208 |
| 20161267 | 20062310 | 1.68 | 71.95 | Adjuvant (A) | 2018-05-02 | 2018-05-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100474949 |
| 20161268 | 20062311 | 1.63 | 75.2 | Palliative (P) | 2016-08-10 | 2016-08-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100413930 |
| 20161269 | 20062312 | 1.84 | 65 | Palliative (P) | 2018-08-30 | 2018-09-19 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100470861 |
| 20161271 | 20062313 | 1.74 | 84.5 | Palliative (P) | 2017-03-15 | 2017-03-23 | ECX | 02 | N | ECX | 100833753 |
| 20161275 | 20062314 | 1.68 | 46.2 | Neo-adjuvant (N) | 2019-07-09 | 2019-08-05 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101472470 |
| 20161276 | 20062315 | 1.78 | 96.3 | Palliative (P) | 2017-09-20 | 2017-10-01 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100399571 |
| 20161278 | 20062316 | 1.56 | 82.4 | Palliative (P) | 2016-11-20 | 2016-11-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101809664 |
| 20161279 | 20062317 | 1.65 | 71 | Curative (C) | 2018-07-29 | 2018-07-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100964857 |
| 20161284 | 20062318 | 1.7 | 63.5 | Adjuvant (A) | 2018-09-19 | 2018-09-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100945446 |
| 20161285 | 20062319 | 1.71 | 77.2 | Curative (C) | 2019-09-11 | 2019-09-20 | ECX | N | N | ECX | 101589825 |
| 20161286 | 20062320 | 1.73 | 63.8 | Neo-adjuvant (N) | 2016-04-11 | 2016-04-11 | ECX | 02 | N | CAPECITABINE + GEMCITABINE | 100460096 |
| 20161287 | 20062321 | 1.7 | 55 | Adjuvant (A) | 2016-04-28 | 2016-05-12 | ECX | N | N | ECX | 100709700 |
| 20161288 | 20062322 | 1.83 | 76 | Neo-adjuvant (N) | 2017-10-06 | 2017-10-07 | ECX | N | N | ECX | 100752153 |
| 20161292 | 20062323 | 1.69 | 61 | Palliative (P) | 2018-05-21 | 2018-06-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101532218 |
| 20161293 | 20062324 | 1.76 | 95.6 | Neo-adjuvant (N) | 2019-02-26 | 2019-03-09 | ECX | N | N | ECX | 101545765 |
| 20161296 | 20062325 | 1.54 | 57 | Palliative (P) | 2019-03-22 | 2019-04-18 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 100451106 |
| 20161297 | 20062326 | 1.57 | 71.2 | Curative (C) | 2016-12-11 | 2016-12-25 | ECX | N | N | ECX | 100984562 |
| 20161298 | 20062327 | 1.59 | 88.5 | Palliative (P) | 2017-07-07 | 2017-07-28 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 101083661 |
| 20161301 | 20062328 | 1.85 | 58.6 | Palliative (P) | 2019-04-20 | 2019-04-21 | ECX | N | N | ECX | 101715334 |